Go Pro

The Pennant Group (PNTG) Competitors

The Pennant Group logo
$37.08 -0.74 (-1.96%)
As of 08/28/2026 04:00 PM Eastern

PNTG vs. LFST, BLLN, CRVL, OPCH, and AVAH

Should you buy The Pennant Group stock or one of its competitors? The Pennant Group's main competitors and comparable companies include LifeStance Health Group (LFST), Billiontoone (BLLN), CorVel (CRVL), Option Care Health (OPCH), and Aveanna Healthcare (AVAH). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does The Pennant Group compare to LifeStance Health Group?

The Pennant Group (NASDAQ:PNTG) and LifeStance Health Group (NASDAQ:LFST) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

The Pennant Group has a beta of 1.26, meaning that its stock price is 26% more volatile than the broader market. Comparatively, LifeStance Health Group has a beta of 1.14, meaning that its stock price is 14% more volatile than the broader market.

In the previous week, The Pennant Group had 5 more articles in the media than LifeStance Health Group. MarketBeat recorded 12 mentions for The Pennant Group and 7 mentions for LifeStance Health Group. The Pennant Group's average media sentiment score of 1.74 beat LifeStance Health Group's score of 1.07 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
11 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
LifeStance Health Group
5 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

The Pennant Group currently has a consensus price target of $41.60, suggesting a potential upside of 12.19%. LifeStance Health Group has a consensus price target of $12.38, suggesting a potential upside of 0.53%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts plainly believe The Pennant Group is more favorable than LifeStance Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
LifeStance Health Group
0 Sell rating(s)
4 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.73

LifeStance Health Group has a net margin of 3.19% compared to The Pennant Group's net margin of 2.93%. The Pennant Group's return on equity of 10.33% beat LifeStance Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
LifeStance Health Group 3.19%3.39%2.33%

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 85.5% of LifeStance Health Group shares are held by institutional investors. 6.9% of The Pennant Group shares are held by insiders. Comparatively, 3.5% of LifeStance Health Group shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

The Pennant Group has higher earnings, but lower revenue than LifeStance Health Group. The Pennant Group is trading at a lower price-to-earnings ratio than LifeStance Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$1.10B1.18$29.58M$0.9041.20
LifeStance Health Group$1.42B3.35$9.66M$0.1394.69

Summary

The Pennant Group beats LifeStance Health Group on 12 of the 17 factors compared between the two stocks.

How does The Pennant Group compare to Billiontoone?

Billiontoone (NASDAQ:BLLN) and The Pennant Group (NASDAQ:PNTG) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their earnings, profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends and risk.

Billiontoone has a net margin of 8.04% compared to The Pennant Group's net margin of 2.93%. The Pennant Group's return on equity of 10.33% beat Billiontoone's return on equity.

Company Net Margins Return on Equity Return on Assets
Billiontoone8.04% 9.96% 5.35%
The Pennant Group 2.93%10.33%4.20%

The Pennant Group has higher revenue and earnings than Billiontoone. The Pennant Group is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Billiontoone$305.11M14.42$7.45M$0.70133.20
The Pennant Group$1.10B1.18$29.58M$0.9041.20

85.9% of The Pennant Group shares are owned by institutional investors. 50.2% of Billiontoone shares are owned by company insiders. Comparatively, 6.9% of The Pennant Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Billiontoone currently has a consensus price target of $126.71, suggesting a potential upside of 35.90%. The Pennant Group has a consensus price target of $41.60, suggesting a potential upside of 12.19%. Given Billiontoone's higher possible upside, research analysts clearly believe Billiontoone is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Billiontoone
1 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
0 Strong Buy rating(s)
2.50
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

In the previous week, The Pennant Group had 5 more articles in the media than Billiontoone. MarketBeat recorded 12 mentions for The Pennant Group and 7 mentions for Billiontoone. The Pennant Group's average media sentiment score of 1.74 beat Billiontoone's score of 0.61 indicating that The Pennant Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Billiontoone
3 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
The Pennant Group
11 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Summary

The Pennant Group beats Billiontoone on 9 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to CorVel?

The Pennant Group (NASDAQ:PNTG) and CorVel (NASDAQ:CRVL) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations.

CorVel has a net margin of 11.72% compared to The Pennant Group's net margin of 2.93%. CorVel's return on equity of 29.92% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
CorVel 11.72%29.92%17.82%

The Pennant Group presently has a consensus target price of $41.60, suggesting a potential upside of 12.19%. Given The Pennant Group's stronger consensus rating and higher possible upside, equities research analysts clearly believe The Pennant Group is more favorable than CorVel.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
CorVel
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
2.00

The Pennant Group has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, CorVel has a beta of 0.98, indicating that its stock price is 2% less volatile than the broader market.

In the previous week, CorVel had 2 more articles in the media than The Pennant Group. MarketBeat recorded 14 mentions for CorVel and 12 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 1.74 beat CorVel's score of 1.02 indicating that The Pennant Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
The Pennant Group
11 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
CorVel
10 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

85.9% of The Pennant Group shares are held by institutional investors. Comparatively, 51.4% of CorVel shares are held by institutional investors. 6.9% of The Pennant Group shares are held by insiders. Comparatively, 39.7% of CorVel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

CorVel has lower revenue, but higher earnings than The Pennant Group. CorVel is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$1.10B1.18$29.58M$0.9041.20
CorVel$958.53M3.68$110.34M$2.2530.77

Summary

The Pennant Group and CorVel tied by winning 8 of the 16 factors compared between the two stocks.

How does The Pennant Group compare to Option Care Health?

The Pennant Group (NASDAQ:PNTG) and Option Care Health (NASDAQ:OPCH) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, analyst recommendations, valuation, dividends and media sentiment.

In the previous week, The Pennant Group had 11 more articles in the media than Option Care Health. MarketBeat recorded 12 mentions for The Pennant Group and 1 mentions for Option Care Health. The Pennant Group's average media sentiment score of 1.74 beat Option Care Health's score of 0.97 indicating that The Pennant Group is being referred to more favorably in the media.

Company Overall Sentiment
The Pennant Group Very Positive
Option Care Health Positive

Option Care Health has higher revenue and earnings than The Pennant Group. Option Care Health is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
The Pennant Group$1.10B1.18$29.58M$0.9041.20
Option Care Health$5.69B0.63$207.59M$1.3317.97

The Pennant Group has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market. Comparatively, Option Care Health has a beta of 0.65, indicating that its share price is 35% less volatile than the broader market.

The Pennant Group currently has a consensus target price of $41.60, indicating a potential upside of 12.19%. Option Care Health has a consensus target price of $29.92, indicating a potential upside of 25.20%. Given Option Care Health's higher possible upside, analysts clearly believe Option Care Health is more favorable than The Pennant Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88
Option Care Health
1 Sell rating(s)
6 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.43

Option Care Health has a net margin of 3.68% compared to The Pennant Group's net margin of 2.93%. Option Care Health's return on equity of 18.74% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
The Pennant Group2.93% 10.33% 4.20%
Option Care Health 3.68%18.74%7.25%

85.9% of The Pennant Group shares are owned by institutional investors. Comparatively, 98.1% of Option Care Health shares are owned by institutional investors. 6.9% of The Pennant Group shares are owned by company insiders. Comparatively, 1.7% of Option Care Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Summary

Option Care Health beats The Pennant Group on 8 of the 15 factors compared between the two stocks.

How does The Pennant Group compare to Aveanna Healthcare?

Aveanna Healthcare (NASDAQ:AVAH) and The Pennant Group (NASDAQ:PNTG) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their media sentiment, earnings, institutional ownership, profitability, valuation, analyst recommendations, risk and dividends.

Aveanna Healthcare has a net margin of 10.56% compared to The Pennant Group's net margin of 2.93%. Aveanna Healthcare's return on equity of 80.70% beat The Pennant Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Aveanna Healthcare10.56% 80.70% 7.42%
The Pennant Group 2.93%10.33%4.20%

Aveanna Healthcare has higher revenue and earnings than The Pennant Group. Aveanna Healthcare is trading at a lower price-to-earnings ratio than The Pennant Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Aveanna Healthcare$2.43B1.19$225.03M$1.2310.83
The Pennant Group$1.10B1.18$29.58M$0.9041.20

Aveanna Healthcare presently has a consensus target price of $13.50, suggesting a potential upside of 1.35%. The Pennant Group has a consensus target price of $41.60, suggesting a potential upside of 12.19%. Given The Pennant Group's stronger consensus rating and higher possible upside, analysts clearly believe The Pennant Group is more favorable than Aveanna Healthcare.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Aveanna Healthcare
0 Sell rating(s)
5 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.67
The Pennant Group
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.88

In the previous week, Aveanna Healthcare had 29 more articles in the media than The Pennant Group. MarketBeat recorded 41 mentions for Aveanna Healthcare and 12 mentions for The Pennant Group. The Pennant Group's average media sentiment score of 1.74 beat Aveanna Healthcare's score of 0.49 indicating that The Pennant Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Aveanna Healthcare
17 Very Positive mention(s)
5 Positive mention(s)
6 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
The Pennant Group
11 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

Aveanna Healthcare has a beta of 1.9, indicating that its stock price is 90% more volatile than the broader market. Comparatively, The Pennant Group has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market.

88.0% of Aveanna Healthcare shares are held by institutional investors. Comparatively, 85.9% of The Pennant Group shares are held by institutional investors. 5.3% of Aveanna Healthcare shares are held by company insiders. Comparatively, 6.9% of The Pennant Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Summary

Aveanna Healthcare beats The Pennant Group on 11 of the 17 factors compared between the two stocks.

Get The Pennant Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PNTG and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PNTG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PNTG vs. The Competition

MetricThe Pennant GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$1.30B$9.87B$7.20B$12.90B
Dividend YieldN/A2.56%2.54%11.28%
P/E Ratio41.2034.69273.1625.45
Price / Sales1.184.90605.0076.62
Price / Cash28.93120.5976.7453.00
Price / Book3.204.0012.986.14
Net Income$29.58M$312.92M$3.48B$348.86M
7 Day Performance-4.63%-1.34%0.13%-0.80%
1 Month Performance-9.85%0.93%7.08%4.13%
1 Year Performance54.44%15.34%24.67%15.17%

The Pennant Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PNTG
The Pennant Group
4.1369 of 5 stars
$37.08
-2.0%
$41.60
+12.2%
+54.4%$1.30B$1.10B41.209,700
LFST
LifeStance Health Group
3.2621 of 5 stars
$12.15
-1.1%
$12.38
+1.9%
+124.6%$4.76B$1.42B93.4710,961
BLLN
Billiontoone
4.1598 of 5 stars
$96.22
-3.8%
$126.71
+31.7%
N/A$4.72B$305.11M137.46620
CRVL
CorVel
1.2685 of 5 stars
$70.36
+0.3%
N/A-22.2%$3.58B$958.53M31.275,239
OPCH
Option Care Health
4.1241 of 5 stars
$24.04
+1.7%
$29.92
+24.5%
-16.7%$3.54B$5.65B18.088,266

Related Companies and Tools


This page (NASDAQ:PNTG) was last updated on 8/30/2026 by MarketBeat.com Staff.
From Our Partners